SRXH SRx Health Solutions, Inc.

CIK 0001471727 50 ready 8-Ks latest July 10, 2026, 4:50 PM ET RSS · JSON

Activity: NORMAL 3 filings / 30d vs 2 baseline Risk accumulating: auditor change (2)

Ready 8-Ks 50

Latest filing July 10, 2026, 4:50 PM ET

Top materiality 0.90

Event mix other_material ×26 · m_and_a ×10 · regulatory ×6

Sentiment 12 pos · 11 neg · 27 neu

Latest earnings reported 2026-Q2

Executive change recent →

SHENANIGAN SCORE 3 / 7 see the board

Recent 8-K filings for SRXH

Highest-materiality recent filing

SRx Health Solutions and EMJX Update Merger Progress, Report Treasury Returns

April 17, 2026, 7:59 PM ET M&A materiality 0.90 positive item 7.01 item 9.01

Deployed $18M into Gen2 digital-asset treasury hedging strategy, March 2026 return of 5.69% vs S&P 500 decline of 4.98%.
Through mid-April, achieved approximate gains of 3.5% in hedging pool and 8% in long treasury holdings.

Read filing →

July 10, 2026, 4:50 PM ET other material materiality 0.75 positive item 7.01 item 9.01

SRX Global declares $0.05/share dividend, authorizes $20M buyback, reports $3.07 NAV

One-time cash dividend of $0.05/share (~$1M aggregate) payable Aug 3, 2026 to holders of record July 22, 2026.
June 26, 2026, 2:19 PM ET other material materiality 0.10 neutral item 7.01 item 9.01

SRX Global posts investor presentation on website; no substantive details in filing

Company posted investor presentation on June 26, 2026, available on its website.
June 24, 2026, 5:23 PM ET regulatory materiality 0.75 negative item 3.01 item 5.07 item 9.01

SRX Global receives NYSE American delisting notice; approves 1-for-60 reverse split effective July 6

NYSE American notified SRX on June 23, 2026 that stock closed below $0.10 and trading halted; company aims to regain compliance via reverse split.
June 18, 2026, 1:48 PM ET M&A materiality 0.85 positive item 7.01 item 9.01

SRx Health closes EMJX acquisition, changes name to SRX Global, issues 268M+ shares and warrants

Acquired 100% of EMJ Crypto Technologies and CCC Crypto; issued 268.3M common shares, 117.3M exchangeable shares, and 44.4M warrants.
April 22, 2026, 7:59 PM ET other material materiality 0.75 positive item 7.01 item 9.01

SRx Health subsidiary invests >10% of investable capital in AI/space SPV

Halo, Purely for Pets invests >10% of investable capital in Astro Investment XVII, an Astro Capital affiliate SPV.
April 17, 2026, 7:59 PM ET M&A materiality 0.90 positive item 7.01 item 9.01

SRx Health Solutions and EMJX Update Merger Progress, Report Treasury Returns

Deployed $18M into Gen2 digital-asset treasury hedging strategy, March 2026 return of 5.69% vs S&P 500 decline of 4.98%.
March 18, 2026, 7:59 PM ET other material materiality 0.65 neutral item 1.01 item 3.02 item 9.01 ◈ Equity Issuances ×2◈ Material Agreements

SRx Health Solutions raises up to $8.0M via Series B preferred and warrants; initial close $4.528M

Securities Purchase Agreement for up to 10,000 Series B shares ($1,000 stated value) and warrants at $0.3182 exercise price.
March 3, 2026, 6:59 PM ET other material materiality 0.50 neutral item 1.01 item 9.01 ◈ Material Agreements ×2

SRx Health enters waiver for new Series B preferred stock offering

Existing investors waive participation rights and consent to Series B Preferred Stock ranking pari passu with Series A.
February 20, 2026, 6:59 PM ET regulatory materiality 0.85 negative item 3.01 item 9.01 ◈ Listing & Compliance Notices

SRx Health Solutions receives NYSE American warning letter over 7.5M share issuance without approval

NYSE American issued public warning letter on Feb 18, 2026 citing violations of Sections 301 and 713.
February 12, 2026, 6:59 PM ET other material materiality 0.75 positive item 7.01 item 9.01

SRx Health redeems Series A Preferred for $21.8M, cancels ~125M common shares

Redeemed 17,418 Series A Preferred shares at ~$21.77M; all outstanding shares eliminated.
January 8, 2026, 6:59 PM ET regulatory materiality 0.60 neutral item 3.01 ◈ Listing & Compliance Notices

NYSE American accepts SRx Health's compliance plan; listing extended to July 14, 2026

NYSE accepted plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
December 23, 2025, 6:59 PM ET other material materiality 0.85 neutral item 5.07

SRx Health shareholders OK name change to EMJX, EMJ Crypto acquisition

Stockholders approved name change to EMJX, Inc. and ticker to EMJX, conditioned on closing of transaction.
December 16, 2025, 6:59 PM ET M&A materiality 0.80 neutral item 1.01 item 7.01 item 9.01 ◈ Material Agreements

SRx Health to acquire EMJX in all-stock deal valued at ~$55M; Eric Jackson to become CEO and Chairman

Aggregate purchase price ~$55M payable in stock; transaction unanimously approved by SRx Health Board.
November 20, 2025, 6:59 PM ET other material materiality 0.55 neutral item 5.03 item 9.01 ◈ Governance Changes

SRx Health Solutions increases authorized common stock from 200M to 5B shares

Authorized common shares increased from 200M to 5B via Certificate of Amendment filed Nov 19, 2025.
November 10, 2025, 6:59 PM ET leadership materiality 0.35 positive item 5.02 item 9.01

SRx Health Solutions appoints Sammy Dorf to Board of Directors

Sammy Dorf appointed as director effective November 10, 2025.
October 31, 2025, 7:59 PM ET other material materiality 0.90 neutral item 1.01 item 2.03 item 3.02 item 5.02 item 5.03 item 9.01 ◈ Debt Financings ×2◈ Equity Issuances ×2

SRx Health raises $15.23M in first closing of Series A preferred offering; secures up to $1B equity commitment

First closing of private placement: 19,035 Series A Preferred shares and 54.5M warrants for $15.23M; additional closings at investor option up to $30.46M total.
October 17, 2025, 7:59 PM ET regulatory materiality 0.50 negative item 3.01 item 9.01 ◈ Listing & Compliance Notices ×2

SRx Health receives NYSE American deficiency notice for stockholders' equity below $4M

Received NYSE American notice on Oct 14, 2025 for non-compliance with Section 1003(a)(ii) due to stockholders' equity below $4M and net losses.
October 9, 2025, 7:59 PM ET other material materiality 0.85 negative item 5.07

SRx Health stockholders approve 25x share increase and up to 85:1 reverse split

Authorized shares increased from 200M to 5B; additional reverse split range 15:1 to 85:1 approved.
October 6, 2025, 7:59 PM ET leadership materiality 0.30 neutral item 5.02 item 9.01

SRx Health Solutions appoints Joshua Epstein to board and compensation committee

Joshua A. Epstein appointed to SRx Health Board of Directors, effective October 1, 2025.
September 19, 2025, 7:59 PM ET other material materiality 0.85 negative item 4.01 item 8.01 item 9.01 ◈ Auditor Changes ×2

SRx Health Solutions dismisses auditor, enters CCAA asset sales; identifies $1.8M revenue error

Dismissed CBIZ CPAs, engaged Davidson & Company as auditor for FY2025 ending Sept 30.
August 14, 2025, 7:59 PM ET other material materiality 0.85 negative item 1.01 item 5.02 item 9.01

SRx Health cancels 18.8M shares (60% of total) via settlement; director resigns

18.8M shares forfeited and canceled, representing ~60% of total outstanding Common Stock and Exchangeable Shares.
August 12, 2025, 7:59 PM ET other material materiality 0.70 negative item 8.01 item 9.01

SRx Health Solutions' Canadian subsidiary enters CCAA restructuring; DIP financing obtained

SRx Canada obtained Initial Order under CCAA from Ontario Superior Court, including a stay of proceedings.
July 29, 2025, 7:59 PM ET other material materiality 0.55 neutral item 5.07

SRx Health stockholders approve reverse stock split at ratio up to 60:1 before March 2026

Stockholders holding 51.5% of voting power (17,088,904 shares) approved Reverse Stock Split via written consent on July 23, 2025.
July 16, 2025, 7:59 PM ET leadership materiality 0.70 neutral item 5.02 item 9.01

SRx Health appoints Kent Cunningham CEO; Adesh Vora becomes Executive Chairman; CFO gets raise

Adesh Vora resigned as CEO July 8; replaced by Kent Cunningham, previously President.
July 15, 2025, 7:59 PM ET other material materiality 0.75 positive item 1.01 item 3.02 item 9.01

SRx Health closes $7.3M convertible note financing and secures $50M equity line of credit

Closed $7.3M convertible note financing led by insiders and existing investors; notes bear 8% interest, mature July 2027.
July 11, 2025, 7:59 PM ET other material materiality 0.85 negative item 9.01 item 1.01 item 2.01 item 5.01 item 5.02 item 5.03 item 8.01 ◈ M&A Transactions

SRx Health acquires SRx Canada; FY2024 net loss C$59.4M, goodwill impairment C$26.9M, going concern doubt

SRx Canada revenue C$200.5M for year ended Sep 30, 2024, net loss C$59.4M vs loss C$15.1M prior year.
June 13, 2025, 7:59 PM ET leadership materiality 0.73 neutral item 5.02 item 7.01 item 9.01 ◈ executive_change ×4

SRx Health Solutions appoints new CEO, President, Chairman and CFO

Davender Sohi resigned as President effective June 10, 2025; no dispute cited.
May 7, 2025, 7:59 PM ET other materiality 0.10 neutral item 7.01 item 9.01

SRx Health Solutions posts updated investor presentation on website

Company posted updated presentation to its website on May 6, 2025.
April 30, 2025, 7:59 PM ET M&A materiality 0.90 neutral item 2.01 item 5.01 item 5.02 item 5.03 item 8.01 item 9.01 item 3.02 ◈ Governance Changes◈ M&A Transactions

SRx Health completes reverse merger with Better Choice; rename, new board, $8.8M PIPE

Former SRx Health stockholders own ~84% of combined entity; Better Choice holders retain ~16% (5.4M shares).
April 29, 2025, 7:59 PM ET other material materiality 0.65 negative item 4.01 item 9.01 ◈ Auditor Changes ×2

SRx Health Solutions replaces auditor Marcum with CBIZ CPAs; ongoing material weaknesses

Marcum LLP resigned as auditor April 23, 2025; CBIZ CPAs engaged immediately for FY 2025.
April 25, 2025, 7:59 PM ET other material materiality 0.60 neutral item 7.01 item 9.01

SRx Health Solutions announces spin-out distribution of Halo SPV shares; ticker change to SRXH effective April 30

Stockholders of record as of April 23, 2025 receive one share of Halo SPV Class A Common Stock per share of common stock held.
April 17, 2025, 7:59 PM ET other material materiality 0.85 positive item 7.01 item 9.01

Better Choice sells Asian business for $8.1M; $6.5M cash upfront, 5-year royalty

Sale of Halo's Asian business to CZC Company LTD for total gross proceeds of $8.1 million.
April 17, 2025, 7:59 PM ET M&A materiality 0.60 neutral item 1.01 item 9.01

Better Choice confirms SRx acquisition consideration of 30M shares; closing targeted April 25

Addendum fixes aggregate consideration at 30,000,000 Better Choice common shares for SRx shareholders.
March 31, 2025, 7:59 PM ET earnings materiality 0.50 neutral item 2.02 item 9.01

Better Choice announces Q4/FY2024 results; no specifics provided in filing text

Press release attached as Exhibit 99.1 but not included in available filing text.
March 31, 2025, 7:59 PM ET other material materiality 0.75 positive item 5.07

Better Choice shareholders approve name change to SRX Health Solutions and SRx acquisition

Shareholders approved name change to SRX Health Solutions Inc. and ticker to SRXH (FOR 1,359,116 votes).
February 20, 2025, 6:59 PM ET other material materiality 0.60 neutral item 8.01 item 9.01

Better Choice adjourns special meeting for SRx arrangement to March 21; 71% of shares voted in favor

Special meeting convened and immediately adjourned to March 21, 2025; no business conducted.
January 28, 2025, 6:59 PM ET M&A materiality 0.65 neutral item 1.01 item 9.01

Better Choice amends SRx acquisition: valuation cut to $77M, closing deadline extended to Feb 28

Amendment No. 2 to Arrangement Agreement extends Outside Date from Jan 31, 2025 to Feb 28, 2025.
December 20, 2024, 6:59 PM ET other material materiality 0.10 neutral item 5.07

Better Choice Co. reports 2024 annual meeting voting results

Elected five directors: Conacher, Cunningham, Fronzaglia, Word III, Young (all with >93% FOR votes).
December 10, 2024, 6:59 PM ET M&A materiality 0.50 neutral item 1.01 item 9.01

Better Choice increases Halo spin-out to 17% in SRx Health acquisition amendment

Amendment to Arrangement Agreement increases Halo spin-out from 8% to 17% for stockholders.
November 15, 2024, 6:59 PM ET earnings materiality 0.30 neutral item 2.02 item 9.01

Better Choice announces Q3 2024 results; no financial details in filing

Earnings press release issued November 12, 2024 for Q3 ended September 30, 2024.
November 5, 2024, 6:59 PM ET M&A materiality 0.60 neutral item 7.01 item 9.01

Better Choice posts investor presentation referencing proposed SRx deal; proxy solicitation underway

Company filed an updated investor presentation dated Oct 30, 2024 as Exhibit 99.1.
October 18, 2024, 7:59 PM ET M&A materiality 0.85 positive item 7.01 item 9.01

Better Choice expects combined 2025 revenue ~$270M, EBITDA ~$10M; SRx Health acquisition close imminent

Combined 2025 pro forma revenue over $270M and EBITDA over $10M, based on management assumptions.
September 9, 2024, 7:59 PM ET M&A materiality 0.75 neutral item 1.01 item 3.02 item 7.01 item 9.01

Better Choice Co. acquires SRx Health Solutions in all-stock deal valuing SRx at $80M

SRx to be acquired via statutory amalgamation; equity value $80M, assumes $43M net debt subject to two-way adjustment.
August 26, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Better Choice Q2 net income $2.7M (EPS $2.98) vs $3.0M loss YoY; rev down 19%

Net income of $2.7M in Q2 2024 vs $3.0M loss a year ago; EPS $2.98 vs $(4.27).
August 7, 2024, 7:59 PM ET other material materiality 0.30 neutral item 8.01

Better Choice exercises over-allotment, raising ~$300K more for total ~$5.3M

Underwriter exercised over-allotment to buy 100,000 shares at $3.00/share on Aug 2, 2024.
August 1, 2024, 7:59 PM ET other material materiality 0.70 neutral item 1.01 item 8.01 item 9.01

Better Choice raises $5M in public offering of stock and pre-funded warrants

Sold 639,000 shares at $3.00 and 1,028,000 pre-funded warrants at $2.99 each.
July 15, 2024, 7:59 PM ET regulatory materiality 0.65 neutral item 3.01 item 7.01 item 9.01

NYSE American accepts Better Choice's compliance plan, extends listing through Oct 2025

On July 9, 2024, NYSE American accepted Better Choice's plan to regain compliance with continued listing standards.
July 12, 2024, 7:59 PM ET other material materiality 0.75 negative item 4.01 item 9.01

Better Choice dismisses BDO, appoints Marcum; BDO's reports had going concern

On July 12, 2024, the Board dismissed BDO USA, P.C. as auditor and engaged Marcum LLP for FY2024.
June 21, 2024, 7:59 PM ET other material materiality 0.80 positive item 1.01 item 9.01

Better Choice settles Alphia lawsuit, retires $5.0M senior secured debt and warrants

Retired $5.0M principal + $0.4M PIK interest senior secured debt with Alphia.
May 24, 2024, 7:59 PM ET regulatory materiality 0.30 negative item 3.01 item 9.01

Better Choice receives NYSE American warning for early Q1 results disclosure without prior notice

Issued Q1 2024 press release at 12:50 PM ET on May 17, 2024 without notifying exchange 10 minutes prior, violating Section 401(a).